Home » Stocks » PRGO

Perrigo Company PLC (PRGO)

Stock Price: $42.96 USD 0.31 (0.73%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 5.74B
Revenue (ttm) 5.06B
Net Income (ttm) -162.60M
Shares Out 133.57M
EPS (ttm) -1.20
PE Ratio n/a
Forward PE 16.18
Dividend $0.90
Dividend Yield 2.09%
Trading Day May 7
Last Price $42.96
Previous Close $42.65
Change ($) 0.31
Change (%) 0.73%
Day's Open 42.69
Day's Range 42.58 - 43.46
Day's Volume 761,029
52-Week Range 37.98 - 57.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

You may not have heard of Perrigo, but it's a stellar dividend stock, and one that income investors should make sure to watch. The post Undervalued Perrigo Is A Dividend Stock to Have And to Hold appear...

4 days ago - InvestorPlace

DUBLIN, April 27, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it will release its fiscal first quarter...

1 week ago - PRNewsWire

Perrigo's (PRGO) new products as well as products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

2 weeks ago - Zacks Investment Research

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

DUBLIN, April 19, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a...

2 weeks ago - PRNewsWire

We believe that Perrigo stock, a healthcare company that provides over-the-counter self-care products, including generic drugs and consumer products, is a good buying opportunity at the present time. PR...

2 months ago - Forbes

Perrigo (PRGO) reports dismal fourth-quarter 2020 results. The company signs deal to sell its generic drug business for $1.55 billion.

2 months ago - Zacks Investment Research

Perrigo (PRGO) delivered earnings and revenue surprises of -7.92% and -2.81%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Perrigo Company Plc (NYSE: PRGO) has agreed to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners for $1.55 billion.  The price included a $1.5 billion payment in cash.

2 months ago - Benzinga

Shares of Perrigo (NYSE:PRGO) rose 0.6% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 12.26% over the past year to $0.93, which missed the estima...

2 months ago - Benzinga

DUBLIN, Feb. 23, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, announced today that its Board of Directors approved a ...

2 months ago - PRNewsWire

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.

2 months ago - Zacks Investment Research

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can b...

Other stocks mentioned: HHC, PRTY, CODI, CQP, HOME, WRLD
3 months ago - Benzinga

We believe that Perrigo stock, a healthcare company that provides over-the-counter health and wellness solutions, is a good buying opportunity at the present time. PRGO stock trades near $45 currently a...

4 months ago - Forbes

Let's see if Perrigo Company plc (PRGO) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

4 months ago - Zacks Investment Research

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

In its journey to become a consumer-led player, Perrigo has already achieved its long-term sales targets well ahead of the schedule. Partly helped by pandemic-driven changes to consumer habits, the high...

5 months ago - Seeking Alpha

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment ...

6 months ago - Insider Monkey

Investors liked the company's third-quarter earnings results.

6 months ago - The Motley Fool

Perrigo (PRGO) reports decent third-quarter 2020 results. U.S. consumer self-care segment drives sales.

6 months ago - Zacks Investment Research

The healthcare company delivered both good news and bad news.

6 months ago - The Motley Fool

Perrigo Company plc (PRGO) CEO Murray Kessler on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Perrigo (PRGO) delivered earnings and revenue surprises of 10.71% and -1.44%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

DUBLIN, Nov. 4, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that the Irish High Court, which is a court of first instance, ruled that the issuance of the Notice of Amende...

6 months ago - PRNewsWire

DUBLIN, Nov. 2, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, announced today that it has completed the acquisition of...

6 months ago - PRNewsWire

DUBLIN, Oct. 29, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has been advised by the Irish High Cou...

6 months ago - PRNewsWire

Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.

6 months ago - Zacks Investment Research

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

DUBLIN, Oct. 22, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a ...

6 months ago - PRNewsWire

DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it will release its third quarter financi...

6 months ago - PRNewsWire

These are the healthcare stocks with the best value, fastest growth, and most momentum for October 2020.

Other stocks mentioned: BIIB, BIO, CVS, IMMU, LVGO, MRNA, PODD ...
7 months ago - Investopedia

Perrigo Company plc shares PRGO, -0.16% slid 3% in premarket trade Thursday, after the company said it's voluntarily recalling albuterol sulfate inhalation aerosols over concerns that some may not dispe...

7 months ago - Market Watch

DUBLIN, Sept. 17, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced a voluntary U.S.

7 months ago - PRNewsWire

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2020.

Other stocks mentioned: AZN, BIIB, MNTA, NLTX, RLMD, SNY, SUPN ...
7 months ago - Investopedia

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?

8 months ago - Zacks Investment Research

DUBLIN, Ireland, Aug. 25, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that CEO and President, Murray S.

8 months ago - PRNewsWire

Perrigo Company plc (PRGO) CEO Murray Kessler on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Perrigo (PRGO) reports decent second-quarter 2020 results. The addition of products following Ranir acquisition boosts sales in the quarter.

9 months ago - Zacks Investment Research

Perrigo (PRGO) delivered earnings and revenue surprises of 18.39% and -0.69%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Shares of Perrigo (NYSE:PRGO) rose 0.9% in pre-market trading after the company reported Q2 results.

9 months ago - Benzinga

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Rotation offers opportunity in top stocks and industries.

Other stocks mentioned: BEP, BLL, COST, DE, MMC, PG, TGT ...
9 months ago - Seeking Alpha

Medical Products Industry's Near-Term Outlook Lacks Spark

Other stocks mentioned: ABT, BAX, BSX, HRC, ISRG, MDT, RMD ...
10 months ago - Zacks Investment Research

Perrigo Company PLC (NYSE: PRGO), one of the world’s largest producers of over-the-counter self-care products, is entering the CBD business.

10 months ago - Benzinga

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?

11 months ago - Zacks Investment Research

PRGO can effectively and cost efficiently produce generic drugs, competing with brand names.

1 year ago - Seeking Alpha

Perrigo Company plc (PRGO) CEO Murray Kessler on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Perrigo (PRGO) reports decent first-quarter 2019 results. The addition of products following Ranir acquisition and stock piling due to COVID-19 boosts sales in the quarter.

1 year ago - Zacks Investment Research

Perrigo (PRGO) delivered earnings and revenue surprises of 4.59% and 1.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

About PRGO

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digest... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Dec 16, 1991
CEO
Murray Kessler
Employees
11,500
Stock Exchange
NYSE
Ticker Symbol
PRGO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for Perrigo stock is "Buy." The 12-month stock price forecast is 54.13, which is an increase of 26.00% from the latest price.

Price Target
$54.13
(26.00% upside)
Analyst Consensus: Buy